Abbott India Ltd

Abbott India Management Change

Ms. Sangeeta Shetty has resigned as Company Secretary and Compliance Officer of Abbott India Limited, effective October 28, 2026.

Abbott India Annual General Meeting

Abbott India Ltd held its 82nd Annual General Meeting on August 13, 2026. Key business items, including dividend declaration and appointments, were discussed.

Abbott India Q1 FY27 Results: Net Profit ₹428.5 Cr, Up 17.1% YoY

Abbott India Ltd reported revenue from operations of ₹1,814 Cr (+4.3% YoY) and net profit of ₹428.5 Cr (+17.1% YoY) for Q1 FY27.

Key figure

Net profit ₹428.5 Cr · +17.1% YoY

Abbott India Board Meeting Date

Abbott India will hold a board meeting on August 12, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.

Abbott India Other Announcement

Abbott India Ltd has provided the web-link to access its Annual Report for the financial year 2025-26 to its shareholders.

Abbott India Business Update

Abbott India Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, as required by SEBI Listing Regulations.

Abbott India Annual General Meeting

Abbott India Limited has issued the notice for its 82nd Annual General Meeting, scheduled to be held on August 13, 2026.

Abbott India Annual Report

Abbott India Ltd submitted its Annual Report for FY 2025-26. The company also notified the 82nd AGM scheduled for August 13, 2026.

Abbott India Management Change

Abbott India appointed Ms. Swati Pathak as Associate Director - Operations effective June 1, 2026. She brings 22 years of pharmaceutical experience to the senior management team.

Abbott India Other Announcement

Abbott India Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall adherence to statutory provisions.

Abbott India Annual General Meeting

Abbott India Limited issued a postal ballot notice to appoint Mr. James Wenner and Mr. Neeraj Jain. Shareholders will vote electronically between May 18 and June 16.

Abbott India Dividend

Abbott India fixed July 24, 2026, as the record date for its FY26 final dividend. Payment will commence on or after August 18, 2026.

Abbott India Q4 FY26 Results: Net Profit ₹394.9 Cr, Up 7.6% YoY

Abbott India Ltd reported revenue from operations of ₹1,710 Cr (+6.5% YoY) and net profit of ₹394.9 Cr (+7.6% YoY) for Q4 FY26.

Key figure

Net profit ₹394.9 Cr · +7.6% YoY

Abbott India Financial Results

Abbott India approved FY26 results with a total dividend of Rs. 656 per share. Revenue reached ₹6,929.05 Crore, reflecting steady operational growth and strong shareholder returns.

Value

₹139.4 Cr

Abbott India Board Meeting Date

Abbott India Ltd's Board of Directors will meet on May 11, 2026, to approve audited financial results for the year ended March 31, 2026. The board will also consider recommending a final dividend. Consequently, the company's trading window remains closed until May 13, 2026.

Abbott India Other Announcement

Abbott India Limited informed BSE that it does not qualify as a Large Corporate as of March 31, 2026, under SEBI's debt-sourcing framework. The company reported zero outstanding long-term borrowings. This routine regulatory disclosure confirms that mandated incremental borrowing requirements through debt securities do not apply to the company.

Abbott India Board Meeting Outcome

Abbott India Limited announced board outcomes including the appointment of Mr. Neeraj Jain as Independent Director and Mr. James Wenner as Non-Executive Director. The company also noted the resignations of Ms. Alison Davies and Ms. Anisha Motwani. Additionally, Mr. Amol Metkar was appointed as Plant Director - Goa, effective June 1, 2026.